CD4 and neoplasm: On the other hand, both CD4+ and CD8+ lymphocytes, as well as NK cells, are known to induce PD-L1 expression on tumor cells through an IFN-γ mediated mechanism (17, 18); therefore, it might be possible that an immune-rich TME could in turn induce PD-L1 expression.